Guangdong Jiaying Pharmaceutical Co., Ltd
Simbol: 002198.SZ
SHZ
6.73
CNYTržna cena danes
121.8232
Razmerje P/E
10.9641
Razmerje PEG
3.42B
Kapaciteta MRK
- 0.00%
Donos DIV
Guangdong Jiaying Pharmaceutical Co., Ltd (002198-SZ) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1231.73 | 334 | 234.1 | 239.4 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 660.9 | 200.5 | 50.3 | 0 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 657.68 | 154 | 240.6 | 175.7 | ||||||||||||||||||||
balance-sheet.row.inventory | 347.58 | 84.6 | 82.3 | 73.4 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 5.96 | 1.1 | 0.4 | 1.2 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 2267.86 | 580.2 | 557.4 | 489.7 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 769.11 | 190.4 | 203.7 | 224.2 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 191.46 | 47.2 | 52.4 | 58.3 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 191.46 | 47.2 | 52.4 | 58.3 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | -134.09 | 27.1 | -20.9 | 30.6 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 8.72 | 2.2 | 2.2 | 4.6 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 240.92 | 0.5 | 51.8 | 0 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 1076.11 | 267.4 | 289.2 | 317.7 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 3343.97 | 847.6 | 846.7 | 807.3 | ||||||||||||||||||||
balance-sheet.row.account-payables | 42.13 | 9.2 | 19 | 14.1 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | -2.03 | 0 | 5.8 | 31.1 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 28.03 | 7.5 | 17.2 | 12 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||||||||||||||||
Deferred Revenue Non Current | 1.72 | 0.4 | 0.5 | 0.2 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 139.12 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 118.62 | 40.2 | 47.1 | 5.7 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 140.84 | 35.2 | 35.3 | 34.9 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-liab | 315.92 | 84.6 | 118.2 | 122.9 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 54.45 | 27.2 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 2030.04 | 507.5 | 507.5 | 507.5 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 398.09 | 104.6 | 70.3 | 26.3 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 174.76 | 0 | 27.2 | 27.2 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 370.71 | 123.7 | 123.4 | 123.4 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3028.05 | 763 | 728.4 | 684.5 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3343.97 | 847.6 | 846.7 | 807.3 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-equity | 3028.05 | 763 | 728.4 | 684.5 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3343.97 | - | - | - | ||||||||||||||||||||
Total Investments | 105.91 | 27.1 | 29.4 | 30.6 | ||||||||||||||||||||
balance-sheet.row.total-debt | 5.87 | 0 | 5.8 | 31.1 | ||||||||||||||||||||
balance-sheet.row.net-debt | -564.95 | -133.5 | -178.1 | -208.3 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 27.32 | 43.9 | 1.5 | 19.8 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 18.01 | 25.9 | 28.4 | 28.2 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 2.4 | 1 | -0.6 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -2.4 | -1 | 0.6 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 116.01 | -48.4 | -4.8 | 38.8 | |||||||||||||||||||
cash-flows.row.account-receivables | 118.37 | -86.5 | 9.6 | 9 | |||||||||||||||||||
cash-flows.row.inventory | -2.36 | -8.4 | -0.8 | 2.5 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 44.1 | -14.7 | 27.9 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 2.4 | 1 | -0.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | -48.06 | 5.7 | 26.7 | 10 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 113.28 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -12.26 | -2.7 | -2.3 | -11.7 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 141.97 | 0.1 | 0 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -0.1 | 0 | 0 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -126.83 | 1.6 | 32.5 | 18.5 | |||||||||||||||||||
cash-flows.row.other-investing-activites | -180 | -49.9 | 25.1 | -25 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -176.93 | -51 | 55.2 | -18.2 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -31.1 | -15 | -135 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -0.5 | -1 | -3.8 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 31.1 | 55 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -31.6 | 15.1 | -83.8 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | -64.89 | -55.4 | 122.1 | -5.1 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 567.95 | 183.9 | 239.3 | 117.2 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 632.85 | 239.3 | 117.2 | 122.3 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 113.28 | 27.2 | 51.8 | 96.9 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -12.26 | -2.7 | -2.3 | -11.7 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 101.02 | 24.4 | 49.5 | 85.2 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 499.15 | 533.2 | 659.2 | 574.7 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 184.54 | 185.5 | 228.5 | 141.9 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 314.61 | 347.7 | 430.7 | 432.8 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 10.47 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 13.37 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 219.49 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | -1.19 | -1.1 | 40.7 | 46.3 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 285.61 | 310.4 | 376 | 403.2 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 470.15 | 495.9 | 604.5 | 545.1 | ||||||||||||||||||||
income-statement-row.row.interest-income | 2.17 | 2.1 | 2.3 | 2.6 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.5 | 1 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 219.49 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.14 | 2.1 | -2.8 | -27.8 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -1.19 | -1.1 | 40.7 | 46.3 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0.14 | 2.1 | -2.8 | -27.8 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.5 | 1 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 8.91 | 24.2 | 26.6 | 28.4 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 30.17 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 33.65 | 40.5 | 53.9 | 33.6 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 32.46 | 39.4 | 51.1 | 5.8 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 5.15 | 5.1 | 7.2 | 4.3 | ||||||||||||||||||||
income-statement-row.row.net-income | 27.32 | 34.3 | 43.9 | 1.5 |
Pogosto zastavljeno vprašanje
Kaj je Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) skupna sredstva?
Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) skupna sredstva so 847563113.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 250417163.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.630.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.199.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.055.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.067.
Kaj je Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 34320234.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 0.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 310409681.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 118503980.000.